These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15816856)

  • 21. BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice.
    Nishitomi K; Sakaguchi G; Horikoshi Y; Gray AJ; Maeda M; Hirata-Fukae C; Becker AG; Hosono M; Sakaguchi I; Minami SS; Nakajima Y; Li HF; Takeyama C; Kihara T; Ota A; Wong PC; Aisen PS; Kato A; Kinoshita N; Matsuoka Y
    J Neurochem; 2006 Dec; 99(6):1555-63. PubMed ID: 17083447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion protein (PrPc) promotes beta-amyloid plaque formation.
    Schwarze-Eicker K; Keyvani K; Görtz N; Westaway D; Sachser N; Paulus W
    Neurobiol Aging; 2005; 26(8):1177-82. PubMed ID: 15917101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel approach for studying endogenous abeta processing using cultured primary neurons isolated from APP transgenic mice.
    Qiu Z; Naten DL; Liston JC; Yess J; Rebeck GW
    Exp Neurol; 2001 Jul; 170(1):186-94. PubMed ID: 11421596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional regulation of human FE65, a ligand of Alzheimer's disease amyloid precursor protein, by Sp1.
    Yu HT; Chan WW; Chai KH; Lee CW; Chang RC; Yu MS; McLoughlin DM; Miller CC; Lau KF
    J Cell Biochem; 2010 Mar; 109(4):782-93. PubMed ID: 20091743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome.
    Abrahamson EE; Ikonomovic MD; Ciallella JR; Hope CE; Paljug WR; Isanski BA; Flood DG; Clark RS; DeKosky ST
    Exp Neurol; 2006 Feb; 197(2):437-50. PubMed ID: 16300758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice.
    Ozmen L; Albientz A; Czech C; Jacobsen H
    Neurodegener Dis; 2009; 6(1-2):29-36. PubMed ID: 19066434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice.
    Philipson O; Lannfelt L; Nilsson LN
    FEBS Lett; 2009 Sep; 583(18):3021-6. PubMed ID: 19683527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inverse correlation between amyloid precursor protein and synaptic plasticity in transgenic mice.
    Matsuyama S; Teraoka R; Mori H; Tomiyama T
    Neuroreport; 2007 Jul; 18(10):1083-7. PubMed ID: 17558301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I; Arbel M; Solomon B
    Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
    Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
    J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice.
    Asai M; Hattori C; Iwata N; Saido TC; Sasagawa N; Szabó B; Hashimoto Y; Maruyama K; Tanuma S; Kiso Y; Ishiura S
    J Neurochem; 2006 Jan; 96(2):533-40. PubMed ID: 16336629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice.
    Eckert A; Hauptmann S; Scherping I; Rhein V; Müller-Spahn F; Götz J; Müller WE
    Neurodegener Dis; 2008; 5(3-4):157-9. PubMed ID: 18322377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Megalin interacts with APP and the intracellular adapter protein FE65 in neurons.
    Alvira-Botero X; Pérez-Gonzalez R; Spuch C; Vargas T; Antequera D; Garzón M; Bermejo-Pareja F; Carro E
    Mol Cell Neurosci; 2010 Nov; 45(3):306-15. PubMed ID: 20637285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA interference silencing of the adaptor molecules ShcC and Fe65 differentially affect amyloid precursor protein processing and Abeta generation.
    Xie Z; Dong Y; Maeda U; Xia W; Tanzi RE
    J Biol Chem; 2007 Feb; 282(7):4318-4325. PubMed ID: 17170108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.
    Dedeoglu A; Choi JK; Cormier K; Kowall NW; Jenkins BG
    Brain Res; 2004 Jun; 1012(1-2):60-5. PubMed ID: 15158161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected].
    Lamb BT; Sisodia SS; Lawler AM; Slunt HH; Kitt CA; Kearns WG; Pearson PL; Price DL; Gearhart JD
    Nat Genet; 1993 Sep; 5(1):22-30. PubMed ID: 8220418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein [correction].
    Harris-Cerruti C; Kamsler A; Kaplan B; Lamb B; Segal M; Groner Y
    Eur J Neurosci; 2004 Mar; 19(5):1174-90. PubMed ID: 15016076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.